Examine the socio-economic burden of tuberculosis on patients in remote areas and evaluate government measures to reduce out-of-pocket diagnostic costs.

Q. Examine the socio-economic burden of tuberculosis on patients in remote areas and evaluate government measures to reduce out-of-pocket diagnostic costs. (15 marks, 250-350 words)

India carries roughly 25% of the global TB burden [5], and this burden falls hardest on the rural poor, where geography converts a curable disease into a household financial shock. Reducing diagnostic cost, not merely treatment cost, is therefore central to the National TB Elimination Programme's goal of elimination ahead of the global 2030 target.

Socio-economic burden in remote areas - Catastrophic out-of-pocket cost: before drone-based sample transport, mean patient expenditure for obtaining a TB diagnosis in Yadadri-Bhuvanagiri district, Telangana, was about ₹9,451 [1] — a sum exceeding monthly income for many wage-dependent households. - Diagnostic delay: median turnaround time of 15 days [1] prolongs the infectious window, widening household and community transmission. - Indirect costs: repeated travel to distant TB units means lost wages for daily-wage earners and accompanying family members. - Social costs: delay compounds stigma, malnutrition and school/work dropout, pushing families deeper into poverty — TB as both cause and consequence of deprivation.

Evaluating government measures - Technology-led logistics: ICMR's i-DRONE initiative, with AIIMS Bibinagar and the district NTEP unit, cut mean patient expenditure to ₹91 and diagnosis time to 5 days [1] — a decisive shift of the transport burden from patient to system. - Doorstep screening: the 100-Day TB Elimination Campaign (from December 2024) and the Pradhan Mantri TB Mukt Bharat Abhiyaan have screened over 20 crore vulnerable persons, with more than 6.77 lakh Ni-kshay Mitras supporting patients [2]. - Measurable outcome: TB incidence fell from 237 to 187 per lakh (2015–2024), nearly double the global rate of decline [3]. - Limitations: drone operations remain constrained by weather, payload limits and training needs [1], while WHO has flagged funding pressures threatening TB gains [4].

On balance, the measures are directionally sound and evidence-backed, but demand scaling from pilot to programme. Institutionalising drone corridors in all high-burden remote districts, backed by assured domestic financing, would align NTEP with SDG-3's promise of universal, affordable health access.

(~325 words)

Sources: 1. Update on NTEP — ICMR i-DRONE study on drone-assisted TB sample transport, PIB (2026) — ₹9,451→₹91 cost, 15→5 day turnaround, Telangana study site, operational limits 2. India Speeding Towards TB Elimination, PIB — 100-Day Campaign, screening coverage, Ni-kshay Mitra enrolment 3. TB incidence in India drops 21% from 237 per lakh (2015) to 187 per lakh (2024), PIB — incidence decline data 4. Global gains in tuberculosis response endangered by funding challenges, WHO (2025) — funding risk to TB programmes 5. Global Tuberculosis Report 2025, WHO — India's ~25% share of global TB burden